OPIANT PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q3 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2011 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$278K, a 48.8% increase year-over-year.
  • Opiant Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$1.51M, a 14% increase year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.12M, a 4505% decline from 2020.
  • Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$46.1K, a 109% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2019 was $504K, a 987% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$1.51M -$278K +$265K +48.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$1.78M -$339K +$224K +39.8% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$2M -$400K +$120K +23% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$2.12M -$497K -$362K -266% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 -$1.76M -$543K -$541K -23984% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.22M -$563K -$578K -3755% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$642K -$520K -$596K -778% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$46.1K -$136K -$349K -164% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $303K -$2.26K -$90.3K -103% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $393K $15.4K -$96.4K -86.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $489K $76.6K -$14.9K -16.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $504K $213K +$111K +110% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $393K $88.1K +$66.1K +300% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $327K $112K +$186K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $141K $91.5K +$94.5K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $46.4K $101K +$70.4K +227% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$24K $22K +$37K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$61K -$74K -$102K -364% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $41K -$3K -$27K -113% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $68K $31K +$19.1K +161% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $48.9K -$15K +$7K +31.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $41.9K $28K +$67.5K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$25.6K $24K +$19.7K +463% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$45.4K $11.9K +$43.2K Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q3 2016 -$88.6K -$22K -$12.8K -139% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-04
Q2 2016 -$75.8K -$39.5K +$68.1K +63.3% May 1, 2016 Jul 31, 2016 10-KT 2018-03-07
Q1 2016 -$144K $4.27K +$14.5K Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 -$158K -$31.3K -$26.1K -496% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q3 2015 -$132K -$9.19K +$6.04K +39.7% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-15
Q2 2015 -$138K -$108K -$73.6K -217% May 1, 2015 Jul 31, 2015 10-K 2016-10-28
Q1 2015 -$64.7K -$10.3K -$3.02K -41.7% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 -$61.7K -$5.26K -$41.3K -115% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2014 -$20.4K -$15.2K +$159K +91.3% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-14
Q2 2014 -$179K -$34K -$13.2K -63.5% May 1, 2014 Jul 31, 2014 10-K 2015-10-26
Q1 2014 -$166K -$7.25K +$170K +95.9% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-12
Q4 2013 -$336K $36.1K +$84.7K Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$421K -$174K -$50K -40.2% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q2 2013 -$371K -$20.8K +$26.6K +56.1% May 1, 2013 Jul 31, 2013 10-K 2014-10-27
Q1 2013 -$398K -$177K -$156K -720% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$242K -$48.7K -$45.7K -1523% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$196K -$124K -$111K -820% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 -$85.5K -$47.4K May 1, 2012 Jul 31, 2012 10-K 2013-10-29
Q1 2012 -$21.6K Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$3K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 -$13.5K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.